An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Don Benson, Jr., MD, PhD
Division of Haematology/Oncology - Ohio State University
Principal Investigator - Sherif Farag, MD, PhD
Indiana University
Principal Investigator - Swaminathan Padmanabhan, MD
CTRC Institute for Drug Development - University of Texas at San Antonio
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Mont Sinai Medical Center
New York, New York, United States
- Ohio State University Medical Center
Columbus, Ohio, United States
- Cancer Therapy Research Center at Uthscsa
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Jan 2011
- Completion
- 31 Jan 2011
- Last update posted
- 31 Mar 2016
- Registered enrollment
- 32
- Registry id
- NCT00552396
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.